Form 4 for LFMD LifeMD, Inc.
Accepted 2023-07-13 00:00:00 ET · period of report 2023-01-27 · accession 0001362118-23-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-13 | 2023-01-27+ | LFMD | Benathen Marc David | CFO | M - OptEx | $0.00 | +50.0K | 227.6K | +28% | $0 |
| D | 2023-07-13 | 2023-07-11 | LFMD | Benathen Marc David | CFO | A - Grant | — | +125.0K | 202.6K | +161% | — |
| DM | 2023-07-13 | 2023-01-27+ | LFMD | Benathen Marc David | CFO | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
| D | 2023-07-13 | 2023-07-11 | LFMD | Benathen Marc David | CFO | D - Sale to Iss | — | -200.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-27 | M | A | 25,000 | $0.00 | 77,554 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-11 | A | A | 125,000 | — | 202,554 | D | — | — | (F1) The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021. |
| 3 | Common | Common Stock | 2023-07-11 | M | A | 25,000 | $0.00 | 227,554 | D | — | — | |
| 4 | Derivative | Restricted Stock | 2023-01-27 | M | D | 25,000 | $0.00 | 25,000 | D | — · — to — | 25,000 Common Stock | (F2) Restricted stock converts into common stock on a one-for-one basis. (F3) Restricted stock vested on January 27, 2023. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2023-07-11 | D | D | 200,000 | — | 0 | D | $21.20 · — to — | 200,000 Common Stock | (F1) The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021. |
| 6 | Derivative | Restricted Stock | 2023-07-11 | M | D | 25,000 | $0.00 | 0 | D | — · — to — | 25,000 Common Stock | (F2) Restricted stock converts into common stock on a one-for-one basis. (F1) The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021. |